For the year ending 2025-12-31, OGEN has $10,067,764 in assets. $1,786,359 in debts. $4,399,726 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 4,399,726 | |||
| Short-term investments | 4,000,000 | |||
| Interest receivable | 53,082 | |||
| Prepaid expenses and other current assets | 1,614,956 | |||
| Total current assets | 10,067,764 | |||
| Total assets | 10,067,764 | |||
| Accounts payable and accrued expenses | 1,559,011 | |||
| Short-term notes payable, net of debt issuance costs | 227,348 | |||
| Total liabilities | 1,786,359 | |||
| Common stock, 0.001 par value 350,000,000 shares authorized 4,271,529 and 419,003 shares issued and outstanding at december 31, 2025, and december 31, 2024, respectively | 4,271 | |||
| Additional paid-in capital | 234,905,793 | |||
| Accumulated deficit | -226,628,659 | |||
| Total stockholders equity (deficit) | 8,281,405 | |||
| Total liabilities and stockholders equity (deficit) | 10,067,764 | |||
ORAGENICS INC (OGEN)
ORAGENICS INC (OGEN)